Hims & Hers Health (HIMS) Other Operating Expenses (2020 - 2026)
Hims & Hers Health (HIMS) posted Other Operating Expenses of $318.5 million for Q1 2026, little changed sequentially from $318.1 million in Q4 2025, and up 8.24% YoY from $294.3 million in Q1 2025.
Hims & Hers Health (HIMS) Other Operating Expenses (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Other Operating Expenses for 7 years, with the latest figure at $318.5 million in Q1 2026.
- Quarterly Other Operating Expenses rose 8.24% year-over-year to $318.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 24.29% YoY) and the FY2025 annual result came in at $1.2 billion, up 39.45% from the prior year.
- Other Operating Expenses steadied at $318.5 million in Q1 2026 per HIMS's latest filing, from $318.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $318.5 million in Q1 2026 and troughed at $63.8 million in Q1 2022.
- A 5-year average of $194.4 million and a median of $169.3 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Other Operating Expenses soared 178.91% in 2022, then rose 8.24% in 2026.
- Over 5 years, Other Operating Expenses stood at $108.1 million in 2022, then surged by 46.89% to $158.7 million in 2023, then surged by 75.87% to $279.2 million in 2024, then increased by 13.95% to $318.1 million in 2025, then increased by 0.12% to $318.5 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $318.5 million, $318.1 million, and $309.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Hims & Hers Health | 7.51 Bn | 6.67 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 357.72 Mn |
| Mar 31, 2026 | 318.51 Mn |
| Dec 31, 2025 | 318.12 Mn |
| Sep 30, 2025 | 309.00 Mn |
| Jun 30, 2025 | 284.35 Mn |
| Mar 31, 2025 | 294.27 Mn |
| Dec 31, 2024 | 279.17 Mn |
| Sep 30, 2024 | 229.80 Mn |
| Jun 30, 2024 | 186.38 Mn |
| Mar 31, 2024 | 169.30 Mn |
| Dec 31, 2023 | 158.73 Mn |
| Sep 30, 2023 | 147.69 Mn |
| Jun 30, 2023 | 136.45 Mn |
| Mar 31, 2023 | 123.43 Mn |
| Dec 31, 2022 | 108.06 Mn |
| Sep 30, 2022 | 100.21 Mn |
| Jun 30, 2022 | 77.94 Mn |
| Mar 31, 2022 | 63.78 Mn |
| Dec 31, 2021 | 56.55 Mn |
| Sep 30, 2021 | 51.10 Mn |